Clinical Trials in Ohio

Showing 3881-3900 of 20,938 trials

Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR

NCT06689839

The objective of this study is to compare the safety and effectiveness of the F2 Cerebral Protection System (CPS) to a standard of care control group in patients undergoing Transcatheter Aortic Valve Replacement (TF TAVR)

Aortic Stenosis Treated With TAVIAortic Diseases

EnCompass Technologies, Inc.500 participantsStarted Sep 2025

Naples, Florida, United States • Indianappolis, Indiana, United States • Detroit, Michigan, United States +7 more locations

TERMINATEDPhase 132 miles

A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)

NCT05014139

This study will test a drug called enfortumab vedotin in participants with a type of bladder cancer called non-muscle invasive bladder cancer (NMIBC). This study will also evaluate what the side effects are and if the drug works to treat NMIBC. A side effect is anything a drug does to your body besides treating your disease. In this study enfortumab vedotin will be put into the bladder using a catheter. A catheter is a thin tube that can be put into your bladder.

Urinary Bladder NeoplasmsCarcinoma in SituCarcinoma Transitional Cell+2 more

Astellas Pharma Global Development, Inc.37 participantsStarted Dec 2021

Gilbert, Arizona, United States • Scottsdale, Arizona, United States • Los Angeles, California, United States +29 more locations

Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR

A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)

Find Trials by Condition in Ohio

Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors

A Randomized, Double-Blind, Placebo-Controlled Trial of IkT-148009 in Untreated Parkinson's Disease

Establishment of ProNephro AKI (NGAL) Cut Off Value for Risk Assessment of Moderate to Severe Acute Kidney Injury in Adults

Surgery With or Without Postoperative Intensity Modulated Radiation Therapy in Treating Patients With Urothelial Bladder Cancer

Allergic Disease Onset Prevention Study

oHSV2-PD-L1/CD3-BsAb Administered Via Intratumoral Injection

Gene Transfer Clinical Trial for Infantile and Late Infantile Krabbe Disease Treated Previously With HSCT

Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM.

UBX-303061 in Subjects With Relapsed/Refractory B-Cell Malignancies

Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)

Comparison of Transforming Powder Dressing to NPIAP Recommended Standard of Care Therapies in Stage 2, 3 and 4 Pressure Injuries

The Synergy Disc To Anterior Cervical Discectomy and Fusion

Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation

VY7523-102: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study in Participants With Early Alzheimer's Disease

ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer

A Novel Posttraumatic Stress Disorder Treatment for Veterans With Moral Injury

Concentrated Bone Marrow Aspirate in Revision ACL Reconstruction

A Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site